AbbVie CDR (CAD Hedged) (ABBV)
Toronto Exchange · Canada · prices in CAD · close of 23 Oct 2026
Key indicators
| Last close | CAD 39.60 |
|---|---|
| 52-week range | 26.89 – 40.26 |
| Return, 1 month / 3 months | +8.2% / +11.2% |
| Return, 1 year / 3 years | +25.8% / +105.6% |
| Trend | Uptrend |
| RSI (14) | 67 |
| Volatility (1 year) | 26.7% |
| Worst drawdown (1 year) | -16.1% |
| Average daily value traded | 0.18M CAD |
| Dividend yield | 2.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
Summary
AbbVie CDR (CAD Hedged) (ABBV) trades on the Toronto Exchange in Canada. It last closed at CAD 39.60 on 23 October 2026.
Its price-based Market X-Ray is 69 out of 100 (a fair price profile), ranking 144 of 870 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 25.8% and over the last three months it rose 11.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Toronto Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 90 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 22.1% | ||
| From 52-week high | -1.5% | ||
| Momentum | 77 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 11.2% | ||
| 6-month return | 41.7% | ||
| 12-month return, skipping the last month | 16.3% | ||
| Stability (higher is calmer) | 78 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 26.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -16.1% | ||
| Liquidity | 32 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.18M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | 32 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.4% | ||
| Years with dividends | 4 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | −0.1% |
|---|---|
| 1 month | +8.2% |
| 3 months | +11.2% |
| 6 months | +41.7% |
| 1 year | +25.8% |
| 3 years | +105.6% |
| 5 years | – |
Signals
| 50-day / 200-day average | 36.72 / 32.44 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.61 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 15 Oct 2026 | CAD 0.2392 |
| 15 Jul 2026 | CAD 0.2381 |
| 15 Apr 2026 | CAD 0.2409 |
| 16 Jan 2026 | CAD 0.2378 |
| 15 Oct 2025 | CAD 0.2308 |
| 15 Jul 2025 | CAD 0.2347 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Toronto Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.